FindTrial
Sign In

The study of the arrhythmia treatment by 3D radiofrequency ablation

The study of the arrhythmia treatment by 3D radiofrequency ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012888
Enrollment
Unknown
Registered
2017-10-05
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arrhythmia

Interventions

2:RFA by 3-dimensional electroanatomic mapping system
1:RFA by 2-dimensinal X-Ray system

Sponsors

The Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 12-80 years old; 2. with no severe cardiopulmonary diseases and other organs diseases; 3. To be able to lay down and cooperate with the performer; 4. a clear rapid arrhythmia (except af): frequent premature ventricular (VPC > 10%), ventricular rate, typical flutter, etc.

Exclusion criteria

Exclusion criteria: 1. pregnant women; 2. severe lung disease, or other vital organs disease; 3. cannot lay down and cooperate with the performer; 4. the abnormal blood vessels; 5. with paroxysmal or persistent atrial fibrillation or atypical flutter.

Design outcomes

Primary

MeasureTime frame
Total fluoroscopy time;success rate;Total procedure time;mapping time;discharge times;complications;—

Countries

China

Contacts

Public ContactLI Bo

The Affiliated Hospital of Guangdong Medical University

libowin@163.com+86 07592386146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026